What is Outpost Bio?
Outpost Bio is at the forefront of computational biology, leveraging artificial intelligence and experimental biology to model the human microbiome. Their innovative platform is designed to predict how microbes interact with drugs, nutrients, and various chemicals. This capability is crucial for developing safer and more effective medicines, enabling personalized therapeutic approaches, and generating predictive insights into human health through data-driven microbial research. The company's focus on making the microbiome computable represents a significant advancement in biotechnology and pharmaceutical development.
How much funding has Outpost Bio raised?
Outpost Bio has raised a total of $3.5M across 1 funding round:
Angel/Pre-Seed
$3.5M
Angel/Pre-Seed (2026): $3.5M with participation from Seedcamp, Defined, and Merantix Capital
Key Investors in Outpost Bio
Seedcamp
Seedcamp is a venture capital firm that supports early-stage startups by providing investment, mentorship, and access to a global network. The firm focuses on ambitious founders and innovative companies across various sectors, helping them grow from initial concepts to successful businesses.
Defined
Defined is a thesis-driven venture capital firm empowering founders shaping the AI Frontier, where data, humans and AI come together to solve problems in radically new ways.
Merantix Capital
Merantix Capital is a venture studio and capital firm that partners with visionary AI founders from pre-idea to seed stage. They focus on defining AI categories and investing in pre-seed and seed stage AI-native companies.
What's next for Outpost Bio?
With this major enterprise-level funding, Outpost Bio is poised to accelerate its research and development initiatives, further refine its AI-driven modeling platform, and potentially expand its therapeutic pipeline. The strategic investment suggests strong confidence from backers in the company's ability to translate its unique technological approach into tangible health solutions. Future growth will likely involve scaling operations, forging strategic partnerships within the pharmaceutical and biotech sectors, and advancing its discoveries towards clinical applications, solidifying its position as a leader in microbiome-based health innovation.
See full Outpost Bio company page
